Radioembolization

This is a treatment used for certain types of liver cancer. It involves putting tiny particles of radioactive material into the liver's blood vessels to block blood flow to the tumor. This stops the cancer from growing.

Procedure

What people who've had Radioembolization report

Every report comes from a Lived member, sent anonymously.

Have you had Radioembolization for Hepatocellular Carcinoma?

NameHow it went

About Radioembolization

Who It's For

Radioembolization is a minimally invasive cancer treatment that delivers radiation directly to tumors in the liver. Through a thin tube threaded into an artery, a doctor releases microscopic beads containing yttrium-90 (Y90), a radioactive substance, into the blood vessels that feed the tumor. The beads lodge there and give off radiation that travels only a few millimeters, so the tumor receives a high dose while most healthy liver is spared. The procedure is also called Y90 therapy, transarterial radioembolization (TARE) or selective internal radiation therapy (SIRT). It works because liver tumors draw almost all their blood from the hepatic artery, while normal liver tissue gets most of its supply from a different vessel, the portal vein. Beads sent through the hepatic artery therefore collect mainly in the tumor. Radioembolization is used for cancers that start in the liver, most often hepatocellular carcinoma, and for cancers that have spread to the liver from elsewhere. It is usually considered when surgery is not possible. Depending on the situation, the goal may be to slow the cancer and extend life, to destroy a small tumor outright with a very high dose, to keep a tumor in check while someone waits for a liver transplant, or to shrink the cancer enough that surgery becomes an option. Treatment choices are usually made by a team of liver, cancer and radiology specialists. Alternatives can include surgery, ablation, chemoembolization (which delivers chemotherapy through the same arteries), external radiation and drug therapy. It is generally not suitable for people whose liver is already working very poorly.

Before the Procedure

Radioembolization usually happens in two stages. The first is a planning procedure called a mapping angiogram, in which the interventional radiologist (a doctor who treats disease through blood vessels using image guidance) studies the liver's arteries with X-ray dye. Vessels that lead to the stomach or bowel may be closed off with tiny coils so beads cannot drift there. A harmless tracer is then injected to simulate treatment, and a scan shows how much would reach the lungs or gut. If the map looks safe, the actual treatment is typically scheduled within about two weeks, and the dose is tailored to the person's liver and tumors. Blood tests check liver and kidney function and clotting, and imaging scans such as CT, MRI or PET measure the tumors. Tell the team about all medicines and supplements, allergies to contrast dye or anesthesia, recent illness, and any chance of pregnancy or breastfeeding, since the treatment involves radiation. You may be asked to stop aspirin, anti-inflammatory pain relievers such as ibuprofen, or blood thinners for several days beforehand, and to change eating and drinking before each procedure. Someone will need to drive you home. Because you may need to limit close contact with others for about a week after treatment, it helps to plan childcare and sleeping arrangements in advance.

During the Procedure

Both the mapping and treatment procedures are done in an interventional radiology suite, usually as outpatient visits, and each typically takes up to about two hours. Most people receive moderate sedation through an IV (a small tube in a vein in the hand or arm), which makes them relaxed and drowsy without a breathing tube; some need general anesthesia. The doctor numbs a spot at the wrist or groin and inserts a catheter, a thin flexible tube, into the artery there. Guided by live X-ray video, the catheter is steered into the arteries of the liver, and the beads are released into the vessels feeding the tumor. Most people feel only pressure at the entry site and a brief warmth from the dye; the bead injection is usually painless, though some people have short-lived pain. Afterward the catheter is removed and pressure or a closure device seals the artery, with no stitches needed.

Recovery & Aftercare

Most people go home the same day after a period of recovery; occasionally someone stays overnight. Rest at home and follow the center's instructions for the puncture site and activity. Fatigue, mild nausea and a reduced appetite are common in the following days, particularly when a large part of the liver was treated, and fatigue can last several weeks. Some people develop post-embolization syndrome, a reaction with nausea, vomiting and fever that usually settles within one to five days and responds to medicine. Most people return to normal activities within days. The beads stay in the liver permanently, but their radiation fades quickly: most is delivered in the first week and almost none remains after a month. The team's radiation safety staff may advise you to avoid sleeping in the same bed as a partner, long close-seated trips and close contact with children or pregnant people for about the first week. Follow-up blood tests and CT or MRI scans are usually done every one to three months. A small, high-dose treatment can show results within about a month, while treatment of a larger area can take three to six months. Contact the care team about pain in the upper abdomen, which can rarely signal a stomach or intestinal ulcer caused by stray beads, and about nausea, vomiting or fever that lasts more than about 10 days.

Risks & Complications

Radioembolization generally causes fewer side effects than many other liver cancer treatments. Small trials comparing it with chemoembolization in early and intermediate liver cancer found similar survival with fewer treatment-related side effects, although larger studies are still needed. The most important risk is damage to the healthy liver. People with cirrhosis (scarring of the liver) or extensive prior chemotherapy who have a large area treated can develop temporary or permanent liver failure, which is why poor liver function rules the treatment out and the dose is planned carefully. If beads reach the stomach or small intestine, they can cause an ulcer; these usually heal with medicine. Rarely, people with large tumors absorb radiation in the lungs, which can cause lasting breathing problems; the mapping study is designed to find this so the dose can be reduced or treatment cancelled. Other risks include infection, which is more likely in people with a stent in their bile ducts and may call for a longer antibiotic course, along with bleeding, bruising or vessel damage where the catheter entered and, rarely, an allergic reaction to the X-ray dye. The treatment does not work for every tumor, and further treatment may be needed.

Questions to Ask Your Doctor

  1. 1.What is the goal of radioembolization for me: to control the cancer, prepare for surgery or a transplant, or something else?
  2. 2.How does it compare with chemoembolization, ablation, surgery or drug treatment in my situation?
  3. 3.How healthy is my liver, and what is my risk of liver damage from treatment?
  4. 4.What radiation precautions should I follow at home, and for how long?
  5. 5.When will we know whether it worked, and what happens if it does not?

Last reviewed • Oct 2026

Educational content, not medical advice.